CN Patent

CN121969357A — Mrtx1133药物组合物

Assigned to Milady Treatment Co · Expires 2026-05-01 · 0y expired

What this patent protects

Patent listed against Krazati.

Drugs covered by this patent

Krazati (ADAGRASIB) · Bristol-Myers Squibb

Patent Metadata

Patent number: CN121969357A
Jurisdiction: CN
Classification: —
Expires: 2026-05-01
Drug substance claim: No
Drug product claim: No
Assignee: Milady Treatment Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.